Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 1/20 | 0.38 |
| ▸ | ELANE | P08246 | 2/20 | 0.35 |
| ▸ | PRTN3 | P24158 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.31 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13816746 | 0.78 | MAPT (0.40) | IDO1MAPTGAARAB9ASMN1; SMN2 | |
| SCHEMBL29226190 | 0.76 | LMNA (0.48) | IDO1ELANEPRTN3GAASMN1; SMN2 | |
| SCHEMBL11032230 | 0.76 | ALDH1A1 (0.40) | IDO1ELANEPRTN3MAPTATM | |
| SCHEMBL26665650 | 0.76 | IDO1 (0.40) | IDO1ELANEPRTN3MAPTATM | |
| SCHEMBL29881429 | 0.73 | IDO1 (0.52) | IDO1MAPTRAB9AATMHTT | |
| SCHEMBL6251669 | 0.73 | IDO1 (0.52) | IDO1MAPTRAB9AATMHTT | |
| SCHEMBL19142380 | 0.73 | MAPT (0.37) | MAPTGAARAB9ASMN1; SMN2SPHK2 | |
| SCHEMBL21204295 | 0.72 | MAPT (0.44) | MAPTGAARAB9ASMN1; SMN2LMNA | |
| SCHEMBL24916452 | 0.72 | RRM2 (0.41) | IDO1RAB9A | |
| SCHEMBL683597 | 0.69 | IDO1 (0.41) | IDO1MAPTGAARAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230026056-A1 | ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF | Lakewood Amedex, Inc. | 2023-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230026056-A1 | ANTIMICROBIAL COMPOUNDS, COMPOSITIONS, AND USES THEREOF | CAT, MPO, NISCH | IDO1 2936/4885ELANE 8/4885PRTN3 585/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.